Concentra Group Holdings Parent, Inc. (CON)
NYSE:CON
Want to see CON full AI Analyst Report?
Earnings Data
Report Date
Jul 30, 2026After Close (Confirmed)
Period Ending
2026 (Q2)Consensus EPS Forecast
0.43Last Year’s EPS
0.35Same Quarter Last Year
Strong Buy
Based on 7 Analysts Ratings
Earnings Call Summary
Earnings Call Sentiment|Positive
The call presented a broadly positive picture: revenue, visit volumes, adjusted EBITDA, margins, and free cash flow all improved materially year‑over‑year, and management raised 2026 guidance. Strategic M&A integrations (Nova and Pivot) are ahead of plan and on‑site clinic growth is accelerating. Offsetting items include modestly higher adjusted G&A tied to separation and investments, elevated absolute debt and leverage that management is working to reduce, and slower employer services growth and state rate timing/mix headwinds. Overall, the positive operational and financial momentum and raised guidance outweigh the manageable challenges.Company Guidance
Revenue Growth — Strong Start to 2026
Total company revenue of $569.6 million in Q1 2026, up 13.7% year‑over‑year versus $500.8 million. Excluding Nova and Pivot contributions, revenue was $520.3 million, a 6.3% increase versus prior year.
Visit Volume Expansion
Total patient visits increased 6.7% to an average of more than 54,000 visits per day. Workers' compensation visits per day rose 9.6% and employer services visits per day increased 4.8%. Excluding Nova, total visits per day increased 2.9%; workers' compensation +6.2%; employer services +0.7%.
Revenue per Visit and Mix Improvement
Overall revenue per visit grew ~3.1% year‑over‑year. Workers' compensation revenue per visit increased 2% (from $209 to $213) and employer services revenue per visit increased 2.7% (from $94 to $97).
Adjusted EBITDA and Margin Expansion
Adjusted EBITDA was $120.7 million in Q1 2026, up 17.6% versus $102.7 million in Q1 2025. Adjusted EBITDA margin improved by 69 basis points to 21.2% (from 20.5%). Trailing twelve‑month adjusted EBITDA reached $450 million, up $85 million (23%) from IPO baseline.
Adjusted Net Income and EPS Growth
Adjusted net income attributable to the company was $51.5 million and adjusted EPS was $0.40 in Q1 2026, up from $42.2 million and $0.33, respectively, in Q1 2025.
On‑Site Health Clinics — Rapid Expansion
On‑site health clinics revenue was $37.2 million in Q1 2026, a 125% increase year‑over‑year (driven largely by Pivot acquisition). Excluding Pivot, on‑site revenue grew 20.9% year‑over‑year. On‑site run‑rate approaching $150 million (from $64 million in 2024).
Successful M&A Integration and Synergies
March 2025 Nova integration complete and ahead of plan, tracking to a transaction multiple below 7.5x adjusted EBITDA. June 2025 Pivot integration complete and ahead of plan, tracking to a transaction multiple below 9x.
Improved Cash Flow and Strengthened Guidance
Operating cash flow of $21.0 million in Q1 (vs $11.7 million prior year). Free cash flow of $9.9 million vs negative $4.0 million prior year. Company raised 2026 guidance: revenue to $2.275B–$2.375B (+$25M midpoints), adjusted EBITDA to $460M–$480M (+$10M range), and free cash flow to $215M–$235M (raised at both ends).
Cost of Services and Center Efficiency Gains
Cost of services improved to 70.1% of revenue from 71.3% in prior year quarter, driven by staffing efficiencies and center level margin gains.
Capital Deployment and Shareholder Returns
Repurchased ~661,000 shares for $15 million during Q1 and paid $8 million in dividends. Board declared a cash dividend of $0.0625 per share. Ended quarter with $61.7 million cash and $1.58 billion total debt, net leverage 3.4x with expectation to finish year below 3x.
Concentra Group Holdings Parent, Inc. (CON) Earnings, Revenues Date & History
CON Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
CON Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 07, 2026 | $23.60 | $24.16 | +2.37% |
Mar 09, 2026 | $22.51 | $22.38 | -0.58% |
Nov 05, 2025 | $19.03 | $18.60 | -2.24% |
Aug 07, 2025 | $20.03 | $21.44 | +7.03% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
FAQ
When does Concentra Group Holdings Parent, Inc. (CON) report earnings?
Concentra Group Holdings Parent, Inc. (CON) is schdueled to report earning on Jul 30, 2026, After Close (Confirmed).
What is Concentra Group Holdings Parent, Inc. (CON) earnings time?
Concentra Group Holdings Parent, Inc. (CON) earnings time is at Jul 30, 2026, After Close (Confirmed).
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is CON EPS forecast?
CON EPS forecast for the fiscal quarter 2026 (Q2) is 0.43.